These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6609885)

  • 1. Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae.
    James SL; Natovitz PC; Farrar WL; Leonard EJ
    Infect Immun; 1984 Jun; 44(3):569-75. PubMed ID: 6609885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
    James SL; Correa-Oliveira R; Leonard EJ
    J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
    James SL
    J Immunol; 1986 May; 136(10):3872-7. PubMed ID: 3084646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
    James SL; Deblois LA; Al-Zamel F; Glaven J; Langhorne J
    J Immunol; 1986 Dec; 137(12):3959-67. PubMed ID: 3097138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
    James SL; Skamene E; Meltzer MS
    J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immune responses between high and low responder strains of mice in the concomitant immunity and vaccine models of resistance to Schistosoma mansoni.
    James SL; Cheever AW
    Parasitology; 1985 Oct; 91 ( Pt 2)():301-15. PubMed ID: 3934632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of P strain mice to respond to vaccination against schistosomiasis correlates with impaired production of IL-12 and up-regulation of Th2 cytokines that inhibit macrophage activation.
    Oswald IP; Caspar P; Wynn TA; Scharton-Kersten T; Williams ME; Hieny S; Sher A; James SL
    Eur J Immunol; 1998 Jun; 28(6):1762-72. PubMed ID: 9645357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo.
    Pearce EJ; James SL
    Parasite Immunol; 1986 Sep; 8(5):513-27. PubMed ID: 3534695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to Schistosoma mansoni in guinea-pigs vaccinated with radiation-attenuated cercariae. T-cell activation of macrophages for larval killing.
    Gordon JR; McLaren DJ
    Immunology; 1988 Feb; 63(2):173-80. PubMed ID: 2832308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement.
    Sher A; Hieny S; James SL; Asofsky R
    J Immunol; 1982 Apr; 128(4):1880-4. PubMed ID: 6801124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ pulmonary responses of T cell and macrophage subpopulations to a challenge infection in mice vaccinated with irradiated cercariae of Schistosoma mansoni.
    Kambara T; Wilson RA
    J Parasitol; 1990 Jun; 76(3):365-72. PubMed ID: 2112597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni.
    Richter D; Reynolds SR; Harn DA
    J Immunol; 1993 Jul; 151(1):256-65. PubMed ID: 8326127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination.
    Coulson PS; Smythies LE; Betts C; Mabbott NA; Sternberg JM; Wei XG; Liew FY; Wilson RA
    Immunology; 1998 Jan; 93(1):55-63. PubMed ID: 9536119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae III. Identification of a mouse strain, P/N, that fails to respond to vaccination.
    James SL; Sher A
    Parasite Immunol; 1983 Nov; 5(6):567-75. PubMed ID: 6657295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-derived cytokines associated with pulmonary immune mechanisms in mice vaccinated with irradiated cercariae of Schistosoma mansoni.
    Smythies LE; Pemberton RM; Coulson PS; Mountford AP; Wilson RA
    J Immunol; 1992 Mar; 148(5):1512-8. PubMed ID: 1538133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
    James SL; Sher A; Lazdins JK; Meltzer MS
    J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance.
    James SL; Cheever AW; Caspar P; Wynn TA
    Infect Immun; 1998 Aug; 66(8):3510-8. PubMed ID: 9673227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung-phase immunity to Schistosoma mansoni. Flow cytometric analysis of macrophage activation states in vaccinated mice.
    Menson EN; Wilson RA
    J Immunol; 1989 Oct; 143(7):2342-8. PubMed ID: 2506284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.